Skip to main content
MyCapitol LogoMyCapitol

S 4152 · 117th Congress

A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

This bill extends a federal program that helps speed up the development of new medicines and medical treatments. The program, called the Critical Path Public-Private Partnerships, brings together the FDA (the government agency that approves drugs), pharmaceutical companies, and medical researchers to work on shared…

Sponsor
Kelly, Mark (D-AZ)
Introduced
2022-05-05
Policy area
Health
Latest action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Digging through Congress... 🔍